NeuroPace | A Smarter Way to Treat Epilepsy
The NeuroPace RNS System is the only FDA-approved epilepsy device that delivers personalized treatment by responding to abnormal brain activity and provides EEG data that can help improve patient care.
Overview
NeuroPace is a company that operates in the neurotechnology sector, headquartered in Mountain View, CA. The company develops and manufactures the RNS® System, an FDA-approved device designed to treat epilepsy by delivering personalized treatment in response to abnormal brain activity. This system is notable for being the first medical device that can monitor and respond to brain activity, similar to how a pacemaker functions for heart rhythms. NeuroPace focuses on creating implantable devices for neurological disorders, with an initial emphasis on epilepsy, which affects about 1% of the global population. The RNS System has received awards for its innovation and has the potential to address other disabling medical disorders that affect many patients worldwide.
Details
- Category
- Medical Equipment Manufacturing
- Headquarters
- Mountain View, CA
- Type
- Public Company
- Founded
- 1999
- Followers
- 31,767
- Locations
- 455 N. Bernardo Avenue Mountain View, CA 94043, US
Funding
Total rounds: 11
Last round: Post IPO debt, Jul 4, 2025
Last round amount: US$ 75.0M
Similar companies
- https://brainpatch.ai/catalog/company/neuronetics-inc-99eec288/367
- https://brainpatch.ai/catalog/company/saluda-medical-424586ca/76
- https://brainpatch.ai/catalog/company/mobiamedical/860
- https://brainpatch.ai/catalog/company/nalu-medical-inc-327c6d76/307
- https://brainpatch.ai/catalog/company/axonics-inc-36ba65fc/595
- https://brainpatch.ai/catalog/company/brainsway-a35a9868/217